Enterprise Products Partners L.P.

SEC Filings

424B5
ENTERPRISE PRODUCTS PARTNERS L P filed this Form 424B5 on 12/01/2017
Entire Document
 


Table of Contents

USE OF PROCEEDS

We intend to use the net proceeds of this offering, after deducting the sales agents’ commissions and our offering expenses, for general partnership purposes as described in the accompanying prospectus.

Affiliates of certain of the sales agents are lenders under EPO’s multi-year revolving credit facility or its 364-day revolving credit agreement, or may hold EPO’s commercial paper notes, and, accordingly, may receive a portion of the proceeds of this offering if we use any net proceeds of this offering to repay debt. In general, EPO’s indebtedness under its multi-year revolving credit facility, its 364-day revolving credit agreement and its commercial paper program was incurred for working capital purposes, capital expenditures and other acquisitions. As of November 30, 2017, EPO had no borrowings outstanding under its multi-year revolving credit facility, which bears interest at a variable rate. Amounts borrowed under EPO’s multi-year revolving credit facility mature in September 2022. As of November 30, 2017, EPO had no borrowings outstanding under its 364-day revolving credit agreement, which bears interest at a variable rate. Amounts borrowed under EPO’s 364-day revolving credit agreement mature in September 2018, although EPO may elect to have the entire principal balance then outstanding under such agreement continued as non-revolving term loans for a period of one additional year, payable in September 2019. As of November 30, 2017, EPO had $2,299 million in principal amount of short-term notes outstanding under its commercial paper program, which had a weighted-average maturity of 41 days, and the weighted-average interest rate on such commercial paper debt was approximately 1.4987% per annum. For additional information, please read “Plan of Distribution” within this prospectus supplement.

 

S-4